The US Food and Drug Administration (FDA) has granted Fast Track Designation to Complement Therapeutics’ CTx001, the ...
Alpelisib/Fulvestrant combo improves OS, PFS for patients with previously-treated PIK3CA-Mutated, HR+, HER2− advanced breast cancer ...
Proteinuria (protein in urine) is common with complement 3 glomeropathy and is a strong predictor of disease progression and end-stage kidney failure.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback